Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: Is it a common cytogenetic abnormality in cancer?

Cancer Letters

Volumn 258, Issue 2, 2007, Pages 262-267

  Panani, Anna D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromosome 11p15; G banding; Ovarian cancer; Recurrent structural chromosomal abnormalities

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CELL CULTURE; CHROMOSOME 11; CHROMOSOME ABERRATION; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; KARYOTYPING; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 36148970852     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.09.006     Document Type: Article

References (33)

1. Lynch H.T., Casey M.J., Lynch J., White T.E., and Godwin A.K. Genetics and ovarian carcinoma. Semin. Oncol. 25 (1998) 265-280
2. Wang N. Cytogenetics and molecular genetics of ovarian cancer. Am. J. Med. Genet. (Semin. Med. Genet.) 115 (2002) 57-163
3. Taetle R., Aickin M., Yang J.-M., Panda L., Emerson J., Roe D., Adair L., Thompson F., Liu Y., Wisner L., Davis J.R., Trent J., and Alberts D.S. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25 (1999) 290-300
4. F. Mitelman, B. Johansson, F. Mertens, Mitelman Database of Chromosome Aberration in Cancer, (2006) .
5. Panani A.D., and Roussos C. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett. 235 (2006) 130-135
6. Bayani J., Brenton J.D., Macgrecor P.F., Beheshti B., Albert M., Nallainathan D., Karaskova J., Rosen B., Murphy J., Laframboise S., Zanke B., and Squire J.A. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridisation and expression microarrays. Cancer Res. 62 (2002) 3466-3476
7. Hu J., Khanna V., Jones M.W., and Surti U. Comparative study of primary and recurrent ovarian serous carcinomas: comparative genomic hybridisation analysis with a potential application for prognosis. Gynecol. Oncol. 89 (2003) 369-375
8. Sham J.S.T., Tang T.C.M., Fang Y., Sun L., Qin L.-X., Wu Q.-L., Xie D., and Guan X.-Y. Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet. Cytogenet. 133 (2002) 39-44
9. Israeli O., Gotlieb W.H., Friedman E., Korach J., Friedman E., Goldman B., Zeltser A., Ben-Baruch G., Rienstein S., and Aviram-Goldring A. Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet. Cytogenet. 154 (2004) 16-21
10. Patael-Karasik Y., Danieli M., Gotlieb W.H., Ben-Baruch G., Schiby J., Barakai G., Goldman B., Aviram A., and Friedman E. Comparative genomic hybridisation in inherited and sporadic tumors in Israel. Cancer Genet. Cytogenet. 121 (2000) 26-32
11. Rao P.H., Harris C.P., Lu X.Y., Li X.-N., Mok S.C., and Lau C.C. Multicolour spectral karyotyping of serous ovarian adenocarcinomas. Genes Chromosomes Cancer 3 (2002) 123-132
12. Taetle R., Aickin M., Panda L., Emerson J., Roe D., Thompson F., Davis J., Trent J., and Alberts D. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes Cancer 25 (1999) 46-52
13. Launonen .V., Mannermaa A., Stenback F., Kosma V.M., Puistola U., Huusko P., Anttila M., Bloigu R., Saarikoski S., Kauppila A., and Winqvist R. Loss of heterozigosity at chromosomes 3,6,8,11,16 and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet. Cytogenet. 122 (2000) 49-54
14. In: Mitelman F. (Ed). An International system for human cytogenetic nomenclature (1995), S. Karger, Basel ISCN 1995
15. Stronach E.A., Sellar G.C., Blenkiron C., Rabiasz G.J., Taylor K.J., Miller E.P., Massie C.E., Al-Nafusi A., Smyth J.F., Porteous D.J., and Gabra H. Identification of clinically relevant genes on chromosome11 in a functional model of ovarian cancer tumor suppression. Cancer Res. 63: (2003) 8648-8655
16. Lu K.H., Weitzel J.N., Kodali S., Welch W.R., Berkowitz R.S., and Moc S.C. A novel 4-cm minimally deleted region on chromosome 11p15.1 associated with high-grade nonmucinous epithelial ovarian carcinomas. Cancer Res. 57 (1997) 387-390
17. Cabra H., Taylor R., Cohen B., Lessels A., Eccles D.M., Leonard R.C.F., Smyth J.F., and Steel C.M. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br. J. Cancer 72 (1995) 367-375
18. Cabra H., Watson J.E.V., Taylor K.J., MacKay J., Leonard R.C.F., Steel C.M., Porteous D.J., and Smyth J.F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56 (1996) 950-954
19. Kim S.W., Kim J.W., Kim Y.T., Kim J.H., Kim S., Yoon B.S., Nam E.J., and Kim H.Y. Analysis of chromosomal changes in serous ovarian carcinomas using high-resolution array comparative genomic hybridization: potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer 46 (2007) 1-9
20. Bignotti E., Tassi R.A., Calza S., Ravaggi A., Bandiera E., Rossi E., Donzelli C., Pasinetti B., Pecorelli S., and Santin A.D. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am. J. Obstet. Gynecol. 196 (2007) 245.e1-245.e11
21. Sayer R.A., Lancaster J.M., Pittman J., Gray J., Whitaker R., Marks J.R., and Berchck A. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol. Oncol. 96 (2005) 355-361
22. Lu L., Katsaros D., Wiley A., Rigault de la Longrais I.A., Puopolo M., Schwartz P., and Yu H. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Gynecol. Oncol. 103 (2006) 990-995
23. Lu L., Katsaros D., Wiley A., Rigault de la Longrais I.A., Risch H.A., Puopolo M., and Yu H. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3 and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. Clin. Cancer Res. 12 (2006) 1208-1214
24. Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis. Markers 23 (2007) 105-112
25. Kim H.T., Choi B.H., Niikawa N., Lee T.S., and Chang S.I. Frequent loss of imprinting of the H19 and IGF-2genes in ovarian tumors. Am. J. Med. Genet. 80 (1998) 391-395
26. Murphy S.K., Huang Z., Wen Y., Spillman M.A., Whitaker R.S., Simel L.R., Nichols T.D., Marks J.R., and Berchuck A. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol. Cancer Res. 4 (2006) 283-292
27. Fechter A., Buettel I., Kuehnel E., Savelyeva L., and Schwab M. Common fragile site FRAIIG and rare fragile site FRAIIB at 11q23.3 encompass distinct genomic regions. Genes Chromosomes Cancer 46 (2007) 98-106
28. 15 in breast cancer. Cancer Genet. Cytogenet. 51 (1991) 183-188
29. Panani A.D., and Roussos C. Non-random structural chromosomal changes in primary gastric cancer. Cancer Lett. 225 (2005) 291-295
30. Panani A.D., Ferti A.D., Raptis S.A., and Roussos C. Novel recurrent structural chromosomal aberrations in primary bladder cancer. Anticancer Res. 24 (2004) 2967-2973
31. 13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 50 (1990) 6410-6416
32. Gicquel C., Raffin-Sanson M.L., Gaston V., Bertagna X., Plouin P.F., Schlumberger M., Louvel A., Luton J.P., and Le Bouc Y. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 82 (1997) 2559-2565
33. Swanson G.P., Dobin S.M., Arber J.M., Arber D.A., Capen C.V., and Diaz J.A. Chromosome 11 abnormalities in Bowen disease of the vulva. Cancer Genet. Cytogenet. 93 (1997) 109-114